Home> Products> cdsco approval for cancer drugs

{ "products": [ { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6822f6b2ab5024c71f211f50", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ZOLMIGRAN", "description": "ZOLMIGRAN is a powerful intravenous medication containing Zoledronic Acid 5mg, designed to treat and prevent bone-related complications in various conditions such as osteoporosis, Paget’s disease of bone, and cancers that affect bones. It belongs to a class of drugs known as bisphosphonates, which help in strengthening bones, reducing bone loss, and preventing fractures. ZOLMIGRAN is often recommended when oral treatments are ineffective or not well-tolerated.\n\nKey Ingredients\nZoledronic Acid (5mg): The active pharmaceutical ingredient responsible for inhibiting bone resorption and maintaining bone density.\n\nKey Benefits\nHelps in the treatment of osteoporosis in postmenopausal women and men at high risk of fractures.\n\nEffective in treating Paget's disease of bone, promoting normal bone formation.\n\nReduces the risk of bone fractures in patients with cancer that has spread to bones.\n\nPrevents skeletal-related events (SREs) like bone pain, fractures, and spinal cord compression in metastatic bone diseases.\n\nOffers a once-yearly infusion for osteoporosis, improving patient compliance.\n\nHow Does It Work?\nZOLMIGRAN works by binding strongly to the bone surface, specifically at sites of active resorption. Zoledronic Acid inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue. By reducing osteoclast activity, it slows down the process of bone resorption, leading to increased bone mass and strength. This action helps in stabilizing bone structure, reducing the likelihood of fractures and other bone complications.\n\nDirections for Use\nZOLMIGRAN is administered as an intravenous infusion by a healthcare professional.\n\nThe usual dosage for osteoporosis is a single 5mg infusion once a year.\n\nFor Paget's disease of bone, a single 5mg infusion is typically sufficient.\n\nAdequate hydration before and after the infusion is recommended.\n\nCalcium and vitamin D supplementation may be prescribed to support bone health.\n\nFollow your doctor’s specific instructions regarding dosage and frequency.\n\nSide Effects\nCommon side effects include flu-like symptoms such as fever, chills, muscle pain, and joint pain after infusion.\n\nMay cause headache, fatigue, and nausea.\n\nCan lead to low blood calcium levels (hypocalcemia), which may require supplementation.\n\nPossible kidney function impairment, especially in patients with pre-existing conditions.\n\nRarely, osteonecrosis of the jaw (ONJ) and atypical femur fractures can occur with long-term use.\n\nAlways inform your doctor of any side effects experienced post-infusion.", "price": 3500.0, "discountamount": 1050.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "require supplementation", "recommended calcium", "usual dosage", "high risk", "jaw onj", "headache fatigue", "flulike symptoms", "healthcare professional", "action helps", "cells responsible", "binding strongly", "onceyearly infusion", "postmenopausal women", "oral treatments", "affect bones", "fractures effective", "bone tissue", "joint pain", "intravenous infusion", "bone fractures", "pagets disease", "osteoporosis pagets disease", "bone pain fractures", "preventing fractures zolmigran", "single 5mg infusion", "reducing osteoclast activity", "treating pagets disease", "atypical femur fractures", "work zolmigran works", "bone complications directions", "increased bone mass", "bone resorption leading", "bone surface specifically", "inhibiting bone resorption", "powerful intravenous medication", "kidney function impairment", "doctors specific instructions", "spinal cord compression", "prevent bonerelated complications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2110, "imageuri": "https://productimages.withfloats.com/actual/6822f6b37108c6234142be46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6822f6b37108c6234142be46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-13T07:37:22.447Z", "updatedon": "2025-05-13T07:38:19.017Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/zolmigran/2110", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "zoledronic acid injection", "category": "ORTHOLOGYRANG", "tags": [ "Zoledronic acid Injection cost", "Zoledronic acid Injection dose", "Zoledronic acid Injection price", "Zoledronic acid infusion protocol", "Zoledronic Acid Injection price in India", "Zoledronic acid injection uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122bef263d0316fb4c9dcb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Gliclazide IP (40 mg) , Pioglitazone Hydrochloride IP (15 mg) , Metformin Hydrochloride IP (500 mg)", "description": "TRI-GLICLAGLAZE 40 is a powerful oral anti-diabetic medication formulated to manage Type 2 Diabetes Mellitus effectively. This combination of three potent drugs—Gliclazide, Pioglitazone, and Metformin—works synergistically to control high blood sugar levels, improve insulin sensitivity, and help patients achieve better glycemic control. TRI-GLICLAGLAZE 40 is designed for patients who struggle to manage blood glucose levels with single medications or lifestyle changes alone. It is a comprehensive solution for long-term diabetes management and reducing the risk of complications related to uncontrolled blood sugar.\n\n \n\nKey Benefits:\n \n\nEffective Blood Sugar Control: TRI-GLICLAGLAZE 40 helps maintain optimal blood glucose levels by targeting different aspects of diabetes management, such as stimulating insulin release, improving insulin sensitivity, and reducing glucose production.\nReduces Insulin Resistance: Pioglitazone and Metformin work together to lower insulin resistance, making it easier for the body to use insulin effectively.\nImproves Long-Term Glycemic Control: By combining three active ingredients, this medication is particularly beneficial for those struggling with glycemic control through diet or monotherapy alone.\nReduces Risk of Diabetes Complications: Controlling blood sugar levels helps prevent diabetes-related complications such as nerve damage, kidney disease, and cardiovascular problems.\nSupports Weight Management: Metformin, in particular, has been known to assist with weight management, which is important for patients with Type 2 Diabetes.\n \n\nHow Does It Work?\n \nTRI-GLICLAGLAZE 40 works through a multi-faceted mechanism to lower blood glucose levels:\n\nGliclazide stimulates the beta cells in the pancreas to release more insulin, which lowers blood sugar levels post-meal.\n\nPioglitazone enhances the body's sensitivity to insulin by promoting glucose uptake in the muscle and fat cells while also decreasing glucose production in the liver.\n\nMetformin reduces the production of glucose in the liver and improves insulin sensitivity. It also decreases the absorption of sugar from the intestines, ensuring better blood sugar control throughout the day.\n\nThis combination of ingredients targets multiple pathways involved in glucose regulation, making it an effective option for individuals with Type 2 Diabetes who require more comprehensive blood sugar control.\n\n \n\nDirections for Use:\n \nTake TRI-GLICLAGLAZE 40 exactly as prescribed by your doctor.\nUsually, it is taken once or twice daily with meals to minimize gastrointestinal discomfort.\nSwallow the tablet whole with water—do not crush or chew the tablet.\nContinue following your diet and exercise plan alongside the medication to achieve optimal blood sugar control.\nDo not skip doses, and consult your healthcare provider if you miss a dose.\n \n\nSide Effects:\n \nLike any medication, TRI-GLICLAGLAZE 40 may cause side effects, although not everyone experiences them. Some common and mild side effects include:\n\nHypoglycemia (Low Blood Sugar): Due to Gliclazide’s insulin-stimulating properties, low blood sugar may occur, especially if meals are skipped or exercise is excessive.\n\nGastrointestinal Issues: Metformin is known to cause digestive problems in some individuals, including nausea, vomiting, diarrhea, or stomach cramps.\n\nWeight Gain: Pioglitazone may cause weight gain in some users due to increased fat storage.\n\nFluid Retention: Pioglitazone may lead to water retention, especially in patients with heart conditions, increasing the risk of heart failure.\n\nHeadache and dizziness: These may occur as the body adjusts to the medication, but they are generally mild and temporary.\n\nLactic Acidosis (rare): A serious but rare side effect of Metformin, this condition requires immediate medical attention and is characterized by muscle pain, breathing difficulties, and weakness.\n\n ", "price": 145.0, "discountamount": 43.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "fat cells", "beta cells", "muscle pain", "fat storage", "Weight Gain", "nerve damage", "Key Benefits", "exercise plan", "Gliclazide IP", "heart failure", "stomach cramps", "kidney disease", "glucose uptake", "water retention", "insulin release", "Lactic Acidosis", "Fluid Retention", "Low Blood Sugar", "heart conditions", "rare side effect", "multiple pathways", "different aspects", "lifestyle changes", "Weight Management", "mild side effects", "Insulin Resistance", "digestive problems", "single medications", "glucose production", "glucose regulation", "three potent drugs", "insulin sensitivity", "healthcare provider", "breathing difficulties", "Diabetes Complications", "comprehensive solution", "Metformin Hydrochloride", "Gastrointestinal Issues", "multi-faceted mechanism", "cardiovascular problems", "high blood sugar levels", "Type 2 Diabetes Mellitus", "three active ingredients", "uncontrolled blood sugar", "Long-Term Glycemic Control", "gastrointestinal discomfort", "immediate medical attention", "optimal blood sugar control", "optimal blood glucose levels", "Pioglitazone Hydrochloride IP", "long-term diabetes management", "Effective Blood Sugar Control", "diabetes-related complications", "insulin-stimulating properties", "comprehensive blood sugar control", "powerful oral anti-diabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1994, "imageuri": "https://productimages.withfloats.com/actual/67122bf4ac30f07ce03345d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122bf4ac30f07ce03345d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:35:43.008Z", "updatedon": "2024-10-18T09:35:43.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclazide-ip-40-mg-pioglitazone-hydrochloride-ip-15-mg-metformin-hydrochloride-ip-500-mg-/1994", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRI - GLICLAGLAZE 40 ", "category": "DIABETIC RANGE", "tags": [ "gliclazide+metformin hydrochloride tablets uses", "Gliclazide Metformin Pioglitazone brand name", "Gliclazide and Metformin hydrochloride tablets Use", "Gliclazide and Metformin Hydrochloride tablets pri", "Gliclazide and Metformin Hydrochloride Tablets bra", "Gliclazide 80 mg and Metformin Hydrochloride table", "", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662cb712bed1f08484d6d9c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ANASTRAZONE 1 ", "description": "ANASTRAZONE 1\nAnastrozole lp (1mg) \nAnastrozole 1 is a medication containing Anastrozole LP, with each tablet containing 1mg of the active ingredient. Anastrozole is classified as an aromatase inhibitor and is commonly prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Here are key points about Anastrazone 1:\n\nMechanism of Action: Anastrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens. By reducing estrogen levels in the body, Anastrozole helps in slowing down or stopping the growth of hormone-sensitive tumors.\n\nIndications: Anastrazone 1 is indicated for the adjuvant treatment of early hormone receptor-positive breast cancer in postmenopausal women. It may also be used in the treatment of advanced breast cancer in postmenopausal women who have not responded well to tamoxifen or other anti-estrogen therapies.\n\nDosage and Administration: The usual recommended dose of Anastrazone 1 is 1mg orally once daily, with or without food. It is important to follow the prescribed dosage and schedule as directed by your healthcare provider.\n\nSide Effects: Common side effects of Anastrazone 1 may include hot flashes, joint pain, headache, nausea, and weakness. Serious side effects such as bone fractures, cardiovascular events, and liver problems are rare but may occur.\n\nPrecautions: Before starting Anastrazone 1, inform your healthcare provider about any existing medical conditions, especially liver disease or osteoporosis. Regular monitoring of bone density and liver function may be recommended during treatment.\n\nDrug Interactions: Anastrazone 1 may interact with certain medications, including estrogen-containing products, tamoxifen, and some cholesterol-lowering drugs. Inform your doctor about all medications, supplements, and herbal products you are taking.\n\nPregnancy and Lactation: Anastrazone 1 is contraindicated during pregnancy and breastfeeding. It may cause harm to the unborn baby or nursing infant. Use effective contraception during treatment with Anastrazone 1 if you are of childbearing age.\n\nStorage: Store Anastrazone 1 at room temperature away from moisture and heat. Keep it out of reach of children and pets.\n\nAlways consult your healthcare provider for personalized guidance and information specific to your medical condition and treatment regimen.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/anastrazone-1-133889", "price": 429.0, "discountamount": 129.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "1mg", "Call", "body", "pets", "heat", "food", "harm", "Order", "Email", "reach", "growth", "Dosage", "nausea", "tablet", "doctor", "infant", "Storage", "moisture", "WhatsApp", "weakness", "headache", "schedule", "children", "Pregnancy", "Mechanism", "androgens", "estrogens", "Lactation", "tamoxifen", "medication", "key points", "joint pain", "Indications", "information", "Precautions", "supplements", "ANASTRAZONE", "unborn baby", "hot flashes", "osteoporosis", "sterisonline", "bone density", "breastfeeding", "liver disease", "liver function", "bone fractures", "Anastrozole LP", "liver problems", "Administration", "herbal products", "estrogen levels", "enzyme aromatase", "childbearing age", "room temperature", "active ingredient", "Drug Interactions", "treatment regimen", "Regular monitoring", "adjuvant treatment", "aromatase inhibitor", "Common side effects", "healthcare provider", "Serious side effects", "postmenopausal women", "cardiovascular events", "personalized guidance", "usual recommended dose", "advanced breast cancer", "effective contraception", "hormone-sensitive tumors", "cholesterol-lowering drugs", "existing medical conditions", "estrogen-containing products", "other anti-estrogen therapies", "early hormone receptor-positive breast cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1517, "imageuri": "https://productimages.withfloats.com/actual/667d31e6576e8da931df6df3.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d31e6576e8da931df6df3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:57:21.017Z", "updatedon": "2024-06-27T09:33:24.204Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//anastrazone-1-/1517", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ANASTRAZONE 1 ", "category": "GENERAL RANGE", "tags": [ "anastrozole 1 mg tablet uses", "anastrozole 1 mg tablet brand name", "anastrozole 1 mg tablet uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c47c2bed1f08484d6c10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TAMOXIFILM 20 ", "description": "TAMOXIFILM 20 \nTamoxifen IP (20mg)\nTamoxifilm 20 contains Tamoxifen IP at a concentration of 20mg per dose. Tamoxifen is a medication commonly used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamoxifen works by blocking the effects of estrogen in the breast tissue, thereby slowing down or stopping the growth of cancer cells that require estrogen to grow.\n\nTamoxifilm 20 is typically prescribed for:\n\nBreast Cancer: It is effective in both early-stage and advanced breast cancer cases. It may be used before surgery to reduce tumor size or after surgery to prevent the recurrence of cancer.\n\nPrevention: Tamoxifen is also used for reducing the risk of developing breast cancer in high-risk individuals, especially those with a family history of breast cancer or certain genetic mutations.\n\nHormone Receptor-Positive Breast Cancer: It is particularly beneficial for hormone receptor-positive breast cancers, where the cancer cells have receptors for estrogen or progesterone.\n\nMetastatic Breast Cancer: In cases where breast cancer has spread to other parts of the body, Tamoxifen can help in controlling the spread and managing the symptoms.\n\nUsage and Dosage:\n\nTamoxifilm 20 is usually taken orally, with or without food.\nThe typical dosage for breast cancer treatment is 20mg to 40mg daily, usually for 5 years or as directed by the healthcare provider.\nFor prevention purposes, the dosage may vary depending on individual risk factors and medical history.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tamoxifilm-20-133689", "price": 32.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "dose", "20mg", "40mg", "food", "SERMs", "drugs", "Order", "Usage", "class", "Email", "spread", "growth", "surgery", "effects", "5 years", "WhatsApp", "symptoms", "receptors", "tumor size", "recurrence", "medication", "TAMOXIFILM", "information", "other parts", "early-stage", "sterispharma", "progesterone", "sterisonline", "cancer cells", "Tamoxifen IP", "breast tissue", "concentration", "family history", "typical dosage", "medical history", "genetic mutations", "healthcare provider", "prevention purposes", "high-risk individuals", "breast cancer treatment", "individual risk factors", "Metastatic Breast Cancer", "advanced breast cancer cases", "selective estrogen receptor modulators", "hormone receptor-positive breast cancers" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1511, "imageuri": "https://productimages.withfloats.com/actual/667d3e4b000f6c164f0965cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e4b000f6c164f0965cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:27:40.343Z", "updatedon": "2024-06-27T10:26:13.622Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tamoxifilm-20-/1511", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TAMOXIFILM 20 ", "category": "NEPHROLOGYRANGE", "tags": [ "", "tamoxifen 20 mg uses", "tamoxifen 20 mg dosage", "", "tamoxifen 20 mg side effects", "tamoxifen 20 mg brand name", "tamoxifen 20 mg buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c321dce9381dfcc59f3d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "THALIDOMILE 100", "description": "THALIDOMILE 100\nThalidomide (100mg)\nThalidomide (100mg) is a medication primarily used to treat certain types of cancer, such as multiple myeloma and leprosy. It belongs to a class of drugs known as immunomodulatory agents. Thalidomide works by affecting the immune system and inhibiting the growth of abnormal cells.\n\nKey points about Thalidomide (100mg):\n\nMedical Uses: Thalidomide is prescribed to patients with multiple myeloma, a type of blood cancer that affects plasma cells. It is also used in the treatment of complications related to leprosy.\nMode of Action: Thalidomide exerts its therapeutic effects by modulating the immune response and interfering with the growth of cancer cells.\nDosage: The standard dosage of Thalidomide is typically 100mg, but this may vary depending on the patient's condition and response to treatment. It is usually taken orally once daily, with or without food.\nSide Effects: Common side effects of Thalidomide include drowsiness, dizziness, constipation, and skin rash. It can also cause more serious side effects such as peripheral neuropathy and blood clots.\nPrecautions: Thalidomide is known to cause severe birth defects and should not be used during pregnancy. Patients must use effective contraception during treatment and for a period after stopping Thalidomide.\nMonitoring: Regular monitoring of blood cell counts, liver function, and pregnancy tests (for women of childbearing potential) is necessary during Thalidomide therapy.\nIt's crucial to take Thalidomide exactly as prescribed by a healthcare professional and to report any unusual symptoms or side effects promptly. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/thalidomile-100-134000", "price": 599.0, "discountamount": 180.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Mode", "Call", "food", "100mg", "Order", "women", "drugs", "Email", "types", "class", "period", "Action", "growth", "leprosy", "patients", "WhatsApp", "dizziness", "treatment", "condition", "skin rash", "medication", "Key points", "drowsiness", "Precautions", "information", "blood clots", "THALIDOMILE", "constipation", "sterispharma", "sterisonline", "plasma cells", "Medical Uses", "cancer cells", "blood cancer", "immune system", "complications", "abnormal cells", "liver function", "pregnancy tests", "immune response", "standard dosage", "unusual symptoms", "multiple myeloma", "blood cell counts", "Regular monitoring", "Thalidomide therapy", "therapeutic effects", "Common side effects", "serious side effects", "severe birth defects", "peripheral neuropathy", "childbearing potential", "healthcare professional", "effective contraception", "immunomodulatory agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1510, "imageuri": "https://productimages.withfloats.com/actual/667d3f16422dd0be26725b95.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3f16422dd0be26725b95.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:21:53.58Z", "updatedon": "2024-06-27T10:29:35.719Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/thalidomile-100/1510", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THALIDOMILE 100", "category": "NEPHROLOGYRANGE", "tags": [ "thalidomide 100mg price", "thalidomide capsules 100 mg", "thalidomide 100mg side effects", "", "thalidomide 100 mg brands" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662bb77db9fdd21801f060a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TAMOXIFLOW 10", "description": "TAMOXIFLOW 10\nTamoxifen IP (10mg)\nTAMOXIFLOW 10 contains Tamoxifen IP in 10mg strength. Tamoxifen is a medication commonly used in the treatment of breast cancer, particularly hormone receptor-positive breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).\n\nTamoxifen works by blocking the effects of estrogen in the breast tissue, which helps to slow down or stop the growth of cancer cells that rely on estrogen to grow. It is often prescribed to both premenopausal and postmenopausal women with certain types of breast cancer.\n\nThis medication is typically taken orally, usually once or twice daily with or without food, as directed by a healthcare professional. It is important to follow the prescribed dosage and schedule strictly to get the most benefit from Tamoxifen treatment.\n\nCommon side effects of Tamoxifen may include hot flashes, nausea, fatigue, vaginal discharge, and changes in menstrual periods. Serious side effects like blood clots, strokes, and uterine cancer are rare but possible, so it's essential to report any unusual symptoms or concerns to your doctor promptly.\n\nTamoxifen should not be used during pregnancy as it may harm the unborn baby. It is also important to inform your doctor about any other medications or supplements you are taking, as they may interact with Tamoxifen.\n\nOverall, TAMOXIFLOW 10 is a valuable medication in the management of breast cancer and should be used under the guidance of a healthcare professional. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tamoxiflow-10-133688\n\n\n\n\n\n\n\n", "price": 28.0, "discountamount": 8.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "drugs", "SERMs", "Order", "class", "types", "Email", "doctor", "growth", "nausea", "dosage", "changes", "strokes", "fatigue", "WhatsApp", "concerns", "guidance", "schedule", "pregnancy", "TAMOXIFLOW", "management", "blood clots", "hot flashes", "supplements", "information", "unborn baby", "sterispharma", "sterisonline", "Tamoxifen IP", "most benefit", "cancer cells", "premenopausal", "10mg strength", "breast tissue", "uterine cancer", "unusual symptoms", "other medications", "menstrual periods", "vaginal discharge", "Tamoxifen treatment", "valuable medication", "Common side effects", "postmenopausal women", "Serious side effects", "healthcare professional", "selective estrogen receptor modulators", "hormone receptor-positive breast cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1507, "imageuri": "https://productimages.withfloats.com/actual/667d40521657b0caada57693.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d40521657b0caada57693.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:49:11.851Z", "updatedon": "2024-06-27T10:34:52.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tamoxiflow-10/1507", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TAMOXIFLOW 10", "category": "NEPHROLOGYRANGE", "tags": [ "tamoxifen 10 mg price", "tamoxifen 10 mg uses", "tamoxifen 10 mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }